Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PTGX | AMGN | GILD | CELG | ILMN |
| Company | Protagonist Therapeutics Inc | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 26.38 | 301.75 | 65.43 | 108.01 | 119.00 |
| High | 26.41 | 302.76 | 65.84 | 108.59 | 119.43 |
| Low | 25.46 | 299.92 | 65.16 | 107.27 | 115.75 |
| Last | 25.66 | 302.06 | 66.11 | 108.24 | 116.32 |
| Change | -0.40 | +2.58 | +0.57 | +0.11 | -2.66 |
| % Change | -1.53% | +0.86% | +0.87% | +0.10% | -2.24% |
| Volume | 46,485 | 572,414 | 922,509 | 191,230,496 | 1,011,139 |
| 20-Day Average Volume | 469,033 | 2,726,916 | 7,279,998 | 16,188,930 | 1,456,879 |
| Previous Close | 26.06 | 299.48 | 65.54 | 108.13 | 118.98 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 26.01 | 275.33 | 66.47 | 108.17 | 122.02 |
| 20-Day Raw Stochastic | 34.26% | 65.75% | 24.49% | 63.25% | 1.35% |
| 20-Day Relative Strength | 44.76% | 63.50% | 35.42% | 64.69% | 38.99% |
| Weighted Alpha | +10.18 | +28.78 | -19.80 | +46.30 | -41.80 |
| Today's Opinion | 8% Buy | 40% Buy | 100% Sell | 100% Buy | 88% Sell |
| Previous Opinion | 8% Buy | 24% Buy | 100% Sell | 100% Buy | 88% Sell |
| Last Month's Opinion | 64% Buy | 24% Sell | 100% Sell | 100% Buy | 40% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.35% since 04/30/24 | +10.02% since 04/30/24 | +0.71% since 04/30/24 | -1.97% since 11/13/19 | -5.74% since 04/30/24 |
| Low | 24.78 on 05/01/24 | 273.38 on 05/01/24 | 64.33 on 05/03/24 | 107.27 on 11/20/19 | 115.75 on 05/07/24 |
| High | 26.58 on 05/03/24 | 322.60 on 05/03/24 | 65.89 on 05/01/24 | 110.53 on 11/14/19 | 127.89 on 05/03/24 |
| 1-Month | |||||
| %Chg | -8.21% since 04/05/24 | +11.65% since 04/05/24 | -5.63% since 04/05/24 | +5.14% since 10/18/19 | -9.21% since 04/05/24 |
| Low | 24.22 on 04/26/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 102.40 on 10/21/19 | 115.73 on 04/18/24 |
| High | 29.21 on 04/09/24 | 322.60 on 05/03/24 | 69.95 on 04/09/24 | 110.70 on 11/13/19 | 135.26 on 04/09/24 |
| 3-Month | |||||
| %Chg | +1.14% since 02/07/24 | +1.87% since 02/07/24 | -11.77% since 02/07/24 | +13.63% since 08/20/19 | -18.86% since 02/07/24 |
| Low | 24.22 on 04/26/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 93.41 on 08/23/19 | 115.73 on 04/18/24 |
| High | 33.34 on 03/01/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 110.70 on 11/13/19 | 147.70 on 02/09/24 |
| 6-Month | |||||
| %Chg | +56.04% since 11/07/23 | +11.17% since 11/07/23 | -18.55% since 11/07/23 | +14.14% since 05/20/19 | +1.30% since 11/07/23 |
| Low | 14.78 on 11/10/23 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 89.08 on 07/23/19 | 89.00 on 11/10/23 |
| High | 33.34 on 03/01/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,528,237 | 160,633,888 | 81,602,352 | 77,035,920 | 18,948,162 |
| Shares Outstanding, K | 58,643 | 536,376 | 1,245,077 | 711,714 | 159,255 |
| Annual Sales | 60,000,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 4,504,000,000 |
| Annual Net Income | -78,960,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | -1,161,000,000 |
| Last Quarter Sales | 60,000,000 | 7,447,000,000 | 6,686,000,000 | 4,520,000,000 | 1,076,000,000 |
| Last Quarter Net Income | 27,340,000 | -113,000,000 | -4,170,000,000 | 1,691,000,000 | -126,000,000 |
| 60-Month Beta | 2.09 | 0.60 | 0.22 | 1.41 | 1.20 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.44 on 02/27/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 0.09 on 05/02/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.71 | 16.07 | 10.99 | 134.01 |